[5] [6] Early-phase clinical trials including a Phase 2 trial published in the New England Journal of Medicine (2023) have reported significant reductions in body weight and improvements in metabolic markers, though this evidence remains preliminary and is not sufficient to establish a clinical dosing or reconstitution standard
Ansari YTM, Rezgui S, Mezziani C, Desjean M, Vachon M et al Bittencourt on behalf of the Pediatric Disease Working Parties of the European Blood and Marrow Transplant group
Theres no downtime, so you can get back to your routine immediately
Keeping track of what you were exposed to before a flare (foods, heat, stress, exercise, or medications) can help you and your doctor identify patterns over time
Modulatory effects of Eschscholzia californica alkaloids on recombinant GABAA receptors